What is the recommended treatment for an 80-year-old woman with newly diagnosed high-grade ureteral carcinoma?

Treatment of High-Grade Ureteral Carcinoma in an 80-Year-Old Woman

Radical nephroureterectomy (RNU) with bladder cuff excision and template-based lymph node dissection remains the standard treatment for high-grade ureteral carcinoma, even in octogenarians, though kidney-sparing approaches may be considered in highly selected cases with specific favorable features. 1

Primary Surgical Management

Standard Approach: Radical Nephroureterectomy

• RNU with complete bladder cuff resection is the gold standard for high-risk upper tract urothelial carcinoma (UTUC), including high-grade ureteral tumors 1, 2
• Template-based lymph node dissection should be performed during RNU for all high-risk disease, as it improves tumor staging and possibly survival with low risk of major complications 1, 3
• The bladder cuff can be removed via either transvesical or extravesical approach—both are acceptable 3

Age Considerations

• While octogenarians present with more advanced disease (50% with invasive T2-T4 tumors vs 41% in younger patients) and higher grade tumors (59% poorly differentiated vs 42% in younger patients), age alone should not preclude definitive surgery 4
• Octogenarians are less likely to undergo extirpative surgery (86% vs 95% in younger patients), but this may represent undertreatment rather than appropriate selection 4
• Even after adjusting for stage and grade, older patients have worse disease-specific survival (hazard ratio 2.64), making aggressive treatment consideration important 4

Alternative Kidney-Sparing Approaches (Highly Selected Cases Only)

When to Consider Conservative Management

Kidney-sparing surgery should only be considered if ALL of the following criteria are met:

• Tumor confirmed as low-grade on biopsy (despite initial high-grade diagnosis, if repeat evaluation shows low-grade features) 1
• No infiltrative features on imaging 1
• Absence of hydronephrosis 1
• Small tumor size (<2 cm) 2
• Unifocal disease 2

Specific Kidney-Sparing Options

• Distal ureterectomy with uretero-neocystostomy may be considered for high-risk UTUC located only in the distal ureter with adequate surgical margins, though this should only be used in highly selected cases where benefits outweigh risks 1
• Ureteroscopy with laser ablation carries approximately 54% ipsilateral recurrence rate and 13% distant metastasis rate, making it suboptimal for high-grade disease 5
• Endoscopic management results in 6.7% mortality within the first 12 months and significantly higher recurrence rates compared to RNU 5

Perioperative Systemic Therapy

Adjuvant Chemotherapy (Preferred Over Neoadjuvant)

• Platinum-based adjuvant chemotherapy is recommended over neoadjuvant treatment for advanced disease (pT2-T4 and/or pN+) 1, 2
• Adjuvant chemotherapy should be considered given the patient's high-grade disease, though renal function after nephrectomy must be adequate 1
• Network meta-analysis suggests adjuvant platinum-based chemotherapy yields superior oncological benefit over immune checkpoint inhibitors 1

Adjuvant Immunotherapy Considerations

• Nivolumab and pembrolizumab are approved for adjuvant treatment in muscle-invasive urothelial carcinoma, but subgroup analyses specifically showed UTUC patients did NOT benefit from adjuvant immunotherapy 1
• Immunotherapy should only be considered if the patient declines or is unfit for adjuvant chemotherapy and has PD-L1 expression >1% 1

Bladder Recurrence Prevention

• Single-dose postoperative intravesical chemotherapy should be administered immediately after RNU to decrease bladder recurrence risk 3
• Both epirubicin and gemcitabine are effective, with gemcitabine showing lower adverse reaction rates (15% vs 49.47%) while maintaining similar efficacy in preventing bladder tumors 6

Critical Pitfalls to Avoid

• Do not rely solely on preoperative staging—clinical tumor staging is inaccurate, which is why template-based lymph node dissection should be performed even when nodes appear negative preoperatively 1
• Do not assume endoscopic management is appropriate for high-grade disease—even with favorable features, there is greater risk of progression after kidney-sparing surgery for high-risk versus low-risk UTUC, with direct impact on survival 1
• Do not withhold surgery based on age alone—while octogenarians have worse outcomes, this reflects both disease biology and potential undertreatment 4